Among those with a borderline response (antibody levels at threshold of 9.1 IU/mL), there were three patients with CVID, one with XLA, one with Hyper-IgM and one with Combined Immunodeficiency. The gene discussed is CD40LG; the disease is common variable immunodeficiency.